The previous page is sending you to https://synapse.zhihuiya.com/blog/synthetic-lethal-new-target-azd3470-a-new-prmt5-inhibitor-of-astrazeneca-has-been-approved-clinically-for-advanced-solid-tumors.

 If you do not want to visit that page, you can return to the previous page.